Krilac, I am also very worried and disappointed by this management, especially considering that the sum of the value of what Gnbt owns is exponential to the current price.
I would like to ask you, in your opinion, why has Excellagen not achieved the success it deserves in recent years? Perhaps the management has been unable to value it, or perhaps it costs too much compared to similar drugs? the covid has certainly not helped, but I don't think it is the main cause .. Perhaps the lack of funds has not allowed adequate publicity?